Edwards Lifesciences launches next-gen transcatheter heart valve in India
Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
The medicine was well tolerated, with no unexpected safety issue
Government policies and competitive industry driving India’s MedTech sector for sustained double-digit growth
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
The accelerated approval is supported by results from part 1 of the ESSENCE trial
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
Athena is also exploring the use of this technology for expanded carrier screening
Subscribe To Our Newsletter & Stay Updated